Qdenga: a vaccine for dengue but not a silver bullet
India’s long wait for a dengue vaccine may finally be coming to an end. Takeda’s tetravalent dengue vaccine, TAK-003 (called ‘Qdenga’), recently received clearance from the Subject Expert Committee (SEC) under the Drugs Controller General of India (DCGI) for use among individuals aged 4 to 60 years. This marks a significant milestone in the country’s…
Read More “Qdenga: a vaccine for dengue but not a silver bullet” »
